Tremor News and Research

Latest Tremor News and Research

Depletion of antioxidant glutathione linked to Parkinson's in mice

Scientists at the Buck Institute have shown that mice suffering from a depletion of the antioxidant glutathione in dopamine-producing neurons developed nerve damage and symptoms associated with Parkinson's disease (PD) in humans.

20 Dec 2007

Immediate relatives of patients with Parkinson's disease face increased risk of depression/anxiety disorders

Immediate relatives (brother, sister, mother, father, son or daughter) of people who have Parkinson's disease are at increased risk for developing depression and anxiety disorders, according to a new study by Mayo Clinic.

4 Dec 2007

Nicotine patches can enhance cognitive function among newly recovering alcoholics with a history of smoking

Detoxified alcoholics in the early stages of recovery tend to have impaired cognitive functioning.

27 Nov 2007

Peptide therapy used to prevent progression of Parkinson's

Researchers have successfully used a peptide to reverse biochemical, cellular and anatomical changes that occur in the brains of mice with Parkinson's disease (PD), and report success in preventing the disease from progression.

21 Nov 2007

New study finds blood-spinal cord barrier compromised in mice with ALS

The blood-spinal cord barrier is functionally impaired in areas of motor neuron damage in mice modeling amyotrophic lateral sclerosis (ALS), report researchers at the University of South Florida Center for Aging and Brain Repair.

21 Nov 2007

Deep brain stimulation to treat Parkinson's makes some act irrationally

An implantable brain device meant to help Parkinson's disease patients better control their movements, has been found to have some worrying side-effects.

29 Oct 2007

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Celgene International Sarl has announced that it's oral cancer drug, Revlimid (lenalidomide) has been granted approval by the Swiss Agency for Therapeutic Products (Swissmedic) for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy.

5 Sep 2007

New and very different schizophrenia drug shows promise

Scientists at Eli Lilly say the first human trial of a new schizophrenia drug shows promise for sufferers of the debilitating mental illness.

3 Sep 2007

Early surgical removal of the ovaries increases a woman's risk of neurological disorders

New research suggests that premenopausal women who have their ovaries removed have an increased risk of developing neurological disorders such as dementia and Parkinsonism.

30 Aug 2007

Ovary removal before menopause leads to memory and movement problems

Women who have their ovaries removed before menopause are at an increased risk of developing memory problems or dementia and movement disorders such as Parkinson's disease, according to two studies published August 29, 2007, in the online edition of Neurology, the medical journal of the American Academy of Neurology.

30 Aug 2007

Risperdal approved for psychiatric conditions in children and adolescents

The U.S. Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.

24 Aug 2007

Antipsychotic drug Risperdal approved for use in children

The Food and Drug Administration (FDA) in the U.S. has given approval for the antipsychotic drug Risperdal to be used to treat schizophrenia and bipolar disorder in children and teenagers.

23 Aug 2007

Proteins involved in fragile X syndrome identified

The interplay of two proteins that bind to messenger RNA, a molecule that mediates translation of the information encoded in genes into proteins, triggers the appearance of fragile X-associated tremor/ataxia syndrome (FTAX), a late-life disorder associated with the gene that causes fragile X syndrome in children, said researchers from Baylor College of Medicine in Houston and Emory University School of Medicine in a report that appears today in the journal Neuron.

17 Aug 2007

New insight into fragile X tremor/ataxia syndrome

Researchers have reported new insight into the pathology underlying a recently identified neurological disorder that strikes middle-aged adults that is caused by alterations in the same gene that causes fragile X syndrome.

17 Aug 2007

Research to look at reasons for the formation of Lewy bodies

A University of Nottingham researcher has been awarded more than £440,000 by the Parkinson’s Disease Society (PDS) to investigate the causes of the condition.

23 Jul 2007

UAB receives grants to investigate novel approaches to treat Parkinson's disease

The Michael J. Fox Foundation (MJFF) has awarded two research grants to UAB (University of Alabama at Birmingham) researchers to investigate novel approaches to treat Parkinson's disease.

13 Jul 2007

Role of environmental factors in the development of Parkinson's disease

Scientists at the Buck Institute for Age Research have shown that combining two environmental toxic substances accelerated age-related degeneration in neurons associated with Parkinson's disease (PD) in mice.

27 Jun 2007

Scientists identify gene responsible for one type of Charcot-Marie-Tooth disorder

Scientists have identified the gene responsible for one type of Charcot-Marie-Tooth disorder, a common inherited neurological disease, thanks to the chance appearance of a strain of impaired 'pale tremor' mice in a University of Michigan research laboratory.

23 Jun 2007

Better understanding of deep brain stimulation

Brain "pacemakers" that have helped ease symptoms in people with Parkinson's disease and other movement disorders seem to work by drowning out the electrical signals of their diseased brains.

1 Jun 2007